Business Description
Aptus Pharma Ltd
ISIN : INE15XJ01010
Compare
Compare
Traded in other countries / regions
544529.India IPO Date
2025-09-30Description
Aptus Pharma Ltd is engaged in the business of marketing and distribution of finished pharmaceutical formulations. It operates through a contract manufacturing model. The group provides a diverse range of pharmaceutical products catering to various therapeutic categories, including anti-infectives, gastrointestinal, antacids, anti-allergic and respiratory, nutritional supplements, pain management, neuro-psychiatric, cardiovascular, anti-diabetic, lipid-lowering, and general wellness products. These are offered across a variety of dosage forms, such as tablets, capsules, softgels, syrups, suspensions, injections, ointments, creams, balms, drops, lotions, vials, powders, gels, and sachets.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.14 | |||||
Equity-to-Asset | 0.54 | |||||
Debt-to-Equity | 0.31 | |||||
Debt-to-EBITDA | 0.95 | |||||
Interest Coverage | 8.82 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 15.79 | |||||
Beneish M-Score | 1.26 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 57 | |||||
3-Year EBITDA Growth Rate | 148 | |||||
3-Year EPS without NRI Growth Rate | 202 | |||||
3-Year FCF Growth Rate | -169.6 | |||||
3-Year Book Growth Rate | 188.8 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 82.44 | |||||
9-Day RSI | 75.52 | |||||
14-Day RSI | 72.04 | |||||
3-1 Month Momentum % | 39.75 | |||||
6-1 Month Momentum % | 113.42 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.83 | |||||
Quick Ratio | 1.12 | |||||
Cash Ratio | 0.05 | |||||
Days Inventory | 176.37 | |||||
Days Sales Outstanding | 90.04 | |||||
Days Payable | 87.63 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Shareholder Yield % | -2.24 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 54.12 | |||||
Operating Margin % | 15.11 | |||||
Net Margin % | 9.92 | |||||
EBITDA Margin % | 16.28 | |||||
FCF Margin % | -14.73 | |||||
OCF Margin % | -14.73 | |||||
ROE % | 26.65 | |||||
ROA % | 13.19 | |||||
ROIC % | 22.69 | |||||
3-Year ROIIC % | 15.32 | |||||
ROC (Joel Greenblatt) % | 47.49 | |||||
ROCE % | 37 | |||||
Years of Profitability over Past 10-Year | 4 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 88.07 | |||||
PE Ratio without NRI | 88.07 | |||||
PS Ratio | 9.92 | |||||
PB Ratio | 19.8 | |||||
Price-to-Tangible-Book | 19.85 | |||||
EV-to-EBIT | 65.3 | |||||
EV-to-EBITDA | 61.78 | |||||
EV-to-Revenue | 10.06 | |||||
EV-to-FCF | -68.28 | |||||
Price-to-Graham-Number | 8.81 | |||||
| Price-to-Net-Current-Asset-Value | 30.73 | |||||
Earnings Yield (Greenblatt) % | 1.53 | |||||
FCF Yield % | -1.48 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Aptus Pharma Ltd Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 465.746 | ||
| EPS (TTM) (₹) | 3.06 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | 72.04 | ||
| 14-Day ATR (₹) | 9.505547 | ||
| 20-Day SMA (₹) | 243.1275 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range (₹) | 32.32 - 270 | ||
| Shares Outstanding (Mil) | 17.15 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Aptus Pharma Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Aptus Pharma Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| 2.5:1 Stock Split | 2026-05-12 | 172.16 (-0.16%) |
Show
Entries
Aptus Pharma Ltd Frequently Asked Questions
What is Aptus Pharma Ltd(BOM:544529)'s stock price today?
The current price of BOM:544529 is ₹269.50. The 52 week high of BOM:544529 is ₹270.00 and 52 week low is ₹32.32.
When is next earnings date of Aptus Pharma Ltd(BOM:544529)?
The next earnings date of Aptus Pharma Ltd(BOM:544529) is .
Does Aptus Pharma Ltd(BOM:544529) pay dividends? If so, how much?
Aptus Pharma Ltd(BOM:544529) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Aptus Pharma Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers